Premium
Italian external and multicentric validation of the MD A nderson C ancer C enter nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
Author(s) -
Gentile Massimo,
Mauro Francesca R.,
Rossi Davide,
Vincelli Iolanda,
Tripepi Giovanni,
Recchia Anna G.,
De Stefano Laura,
Campanelli Melissa,
Giannarelli Diana,
Bossio Sabrina,
Morabito Lucio,
Vigna Ernesto,
Gaidano Gianluca,
Foà Robin,
Morabito Fortunato
Publication year - 2014
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13032
Subject(s) - nomogram , medicine , stage (stratigraphy) , lymphocytosis , gastroenterology , beta 2 microglobulin , oncology , biology , paleontology
Summary We performed an external and multicentric validation of the nomogram and prognostic index ( PI ) proposed by the MD A nderson C ancer C enter to prognostically stratify chronic lymphocytic leukaemia ( CLL ) patients in 1502 CLL cases. All six parameters involved in the nomogram and PI (age, sex, absolute lymphocyte count, number of lymph node groups, R ai stage and β2‐microglobulin) were independently associated with survival. The nomogram was accurate in predicting survival (c‐index = 0·82). According to the PI, 38·7% of patients were at low‐risk, 58·3% at intermediate‐risk and 3% at high‐risk. The estimated median survival times were: not reached for low‐risk, 13·4 years for intermediate‐risk and 3·4 years for high‐risk. The estimated median and 5‐year survival by PI were similar to those originally reported. The PI remained a predictor of survival when analysis was limited to 847 R ai stage 0 ( P < 0·0001) and 151 clinical monoclonal B‐cell lymphocytosis ( cMBL ) cases ( P = 0·033). Finally, the PI allowed prediction of time to therapy in all patients ( P < 0·0001), in R ai 0 ( P < 0·0001) and in cMBL cases ( P = 0·044). Our results confirm the ability of the PI to predict prognosis, even in early stage disease cases. The study also extended the utility of the PI to cMBL cases.